MCC
VCNX icon

Money Concepts Capital’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Money Concepts Capital’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$71 – 3048
2022
Q4 		$71 Buy
+1
New +$124 ﹤0.01% 3179

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Money Concepts Capital's VCNX Position: Q1 2023 in Review

Money Concepts Capital sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2023, closing a stake of 1 share — an estimated $71 sold.

Money Concepts Capital first reported a position in VCNX in Q4 2022 and held it in 1 quarter. The position peaked at $71 in Q4 2022. 24 funds tracked by Wall St. Rank hold VCNX as of Q1 2023.

  • Money Concepts Capital reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 1 Vaccinex, Inc. Common Stock share in Q1 2023, an estimated $71.
  • Money Concepts Capital first reported a position in Vaccinex, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Money Concepts Capital's Vaccinex, Inc. Common Stock position peaked at $71 in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.